Your browser doesn't support javascript.
loading
Post-neoadjuvant treatment with capecitabine and trastuzumab emtansine in breast cancer patients-sequentially, or better simultaneously?
Piroth, Marc D; Krug, David; Sedlmayer, Felix; Duma, Marciana-Nona; Baumann, René; Budach, Wilfried; Dunst, Jürgen; Feyer, Petra; Fietkau, Rainer; Haase, Wulf; Harms, Wolfgang; Hehr, Thomas; Souchon, Rainer; Strnad, Vratislav; Sauer, Rolf.
Affiliation
  • Piroth MD; Dpt. of Radiation Oncology, Wuppertal University Hospital (Helios), Witten/Herdecke University, Heusnerstraße 40, 42283, Wuppertal, Germany. marc.piroth@helios-gesundheit.de.
  • Krug D; University Hospital Schleswig-Holstein, Kiel, Germany.
  • Sedlmayer F; Paracelsus Medical University Hospital Salzburg, Salzburg, Austria.
  • Duma MN; Friedrich-Schiller-University Hospital Jena, Jena, Germany.
  • Baumann R; St. Marien-Krankenhaus Siegen, Siegen, Germany.
  • Budach W; Heinrich-Heine-University Hospital Düsseldorf, Düsseldorf, Germany.
  • Dunst J; University Hospital Schleswig-Holstein, Kiel, Germany.
  • Feyer P; Vivantes Hospital Neukoelln, Berlin, Germany.
  • Fietkau R; University Hospital Erlangen, Erlangen, Germany.
  • Haase W; formerly St.-Vincentius-Hospital Karlsruhe, Karlsruhe, Germany.
  • Harms W; St. Claraspital Basel, Basel, Switzerland.
  • Hehr T; Marienhospital Stuttgart, Stuttgart, Germany.
  • Souchon R; formerly University Hospital, Tübingen, Germany.
  • Strnad V; University Hospital Erlangen, Erlangen, Germany.
  • Sauer R; University Hospital Erlangen, Erlangen, Germany.
Strahlenther Onkol ; 197(1): 1-7, 2021 Jan.
Article in En | MEDLINE | ID: mdl-32737515
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Observational_studies / Risk_factors_studies / Systematic_reviews Limits: Female / Humans Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Observational_studies / Risk_factors_studies / Systematic_reviews Limits: Female / Humans Language: En Year: 2021 Type: Article